Taken together, cochlear gene therapy has been successfully used in the treatment of neurosensory hearing loss and other inner ear disorders. The greatest progress will be achieved, in the near future, in the regeneration of hair cells after use of atonal homolog 1 gene delivered by viral vectors and this may become the best clinical treatment method for certain types of hearing loss. This evidence concerns the gene ATOH1 and inner ear disorder.